Pacific View Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-46,465
Closed -$4.61M 44
2019
Q2
$4.61M Buy
46,465
+38,621
+492% +$3.69M 5% 7
2019
Q1
$865K Buy
7,844
+4,488
+134% +$469K 0.9% 29
2018
Q4
$309K Sell
3,356
-4,677
-58% -$473K 0.36% 44
2018
Q3
$884K Sell
8,033
-28,592
-78% -$2.98M 0.7% 35
2018
Q2
$3.42M Buy
36,625
+14,841
+68% +$1.28M 2.71% 14
2018
Q1
$1.81M Sell
21,784
-20,047
-48% -$1.78M 1.36% 20
2017
Q4
$3.81M Buy
+41,831
New +$3.48M 2.53% 10

Other funds holding PRAH

Pacific View Asset Management's PRAH Position: Q3 2019 in Review

Pacific View Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 46,465 shares — an estimated $4.61M sold.

Pacific View Asset Management first reported a position in PRAH in Q4 2017 and held it in 7 quarters. The position peaked at $4.61M in Q2 2019. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

  • Pacific View Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
  • Pacific View Asset Management sold 46,465 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $4.61M.
  • Pacific View Asset Management first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 7 quarters.
  • Pacific View Asset Management's PRA Health Sciences, Inc. position peaked at $4.61M in Q2 2019.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Pacific View Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.